A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas
Richard Shaffer(Bupa Cromwell Hospital), Karl F. Otto(BC Cancer Agency), E. Vollans(BC Cancer Agency), Sandy Nakano(BC Cancer Agency), Michael McKenzie(Provincial Health Services Authority), Alan Nichol(BC Cancer Agency), Roy Ma(BC Cancer Agency), M. Schmuland(BC Cancer Agency), Ming Fong(BC Cancer Agency), Vitali Moiseenko(BC Cancer Agency)
International Journal of Radiation Oncology*Biology*Physics
June 28, 2009
Cited by 153
Related Papers
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2016|736
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes
|International Journal of Radiation Oncology*Biology*Physics|2009|365
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer
|International Journal of Radiation Oncology*Biology*Physics|2017|319